These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 33336512)
1. Imaging as a tool to accelerate the translation of extracellular vesicle-based therapies for central nervous system diseases. Gao Y; Chu C; Jablonska A; Bulte JWM; Walczak P; Janowski M Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 May; 13(3):e1688. PubMed ID: 33336512 [TBL] [Abstract][Full Text] [Related]
2. Extracellular Vesicles as Drug Delivery Vehicles to the Central Nervous System. Shahjin F; Chand S; Yelamanchili SV J Neuroimmune Pharmacol; 2020 Sep; 15(3):443-458. PubMed ID: 31485884 [TBL] [Abstract][Full Text] [Related]
3. Emerging strategies for labeling and tracking of extracellular vesicles. Li YJ; Wu JY; Wang JM; Hu XB; Xiang DX J Control Release; 2020 Dec; 328():141-159. PubMed ID: 32882270 [TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of extracellular vesicles and future directions in diagnosis and therapy. De Sousa KP; Rossi I; Abdullahi M; Ramirez MI; Stratton D; Inal JM Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023 Jan; 15(1):e1835. PubMed ID: 35898167 [TBL] [Abstract][Full Text] [Related]
5. Heterologous and cross-species tropism of cancer-derived extracellular vesicles. Garofalo M; Villa A; Crescenti D; Marzagalli M; Kuryk L; Limonta P; Mazzaferro V; Ciana P Theranostics; 2019; 9(19):5681-5693. PubMed ID: 31534511 [TBL] [Abstract][Full Text] [Related]
6. Biomimicking Extracellular Vesicles with Fully Artificial Ones: A Rational Design of EV-BIOMIMETICS toward Effective Theranostic Tools in Nanomedicine. Rosso G; Cauda V ACS Biomater Sci Eng; 2023 Nov; 9(11):5924-5932. PubMed ID: 36535896 [TBL] [Abstract][Full Text] [Related]
7. Extracellular Vesicles As Nanomedicine: Hopes And Hurdles In Clinical Translation. Burnouf T; Agrahari V; Agrahari V Int J Nanomedicine; 2019; 14():8847-8859. PubMed ID: 32009783 [TBL] [Abstract][Full Text] [Related]
8. Extracellular Vesicle-Based Hybrid Systems for Advanced Drug Delivery. Rodríguez DA; Vader P Pharmaceutics; 2022 Jan; 14(2):. PubMed ID: 35214000 [TBL] [Abstract][Full Text] [Related]
9. Extracellular vesicles for drug delivery. Vader P; Mol EA; Pasterkamp G; Schiffelers RM Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):148-156. PubMed ID: 26928656 [TBL] [Abstract][Full Text] [Related]
10. Current progression in application of extracellular vesicles in central nervous system diseases. Zhang XM; Huang J; Ni XY; Zhu HR; Huang ZX; Ding S; Yang XY; Tan YD; Chen JF; Cai JH Eur J Med Res; 2024 Jan; 29(1):15. PubMed ID: 38173021 [TBL] [Abstract][Full Text] [Related]
11. Extracellular vesicles for the treatment of central nervous system diseases. Gratpain V; Mwema A; Labrak Y; Muccioli GG; van Pesch V; des Rieux A Adv Drug Deliv Rev; 2021 Jul; 174():535-552. PubMed ID: 33991589 [TBL] [Abstract][Full Text] [Related]
12. In Vivo Tracking of Extracellular Vesicles by Nuclear Imaging: Advances in Radiolabeling Strategies. Almeida S; Santos L; Falcão A; Gomes C; Abrunhosa A Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322484 [TBL] [Abstract][Full Text] [Related]
13. Engineered EVs designed to target diseases of the CNS. Nieland L; Mahjoum S; Grandell E; Breyne K; Breakefield XO J Control Release; 2023 Apr; 356():493-506. PubMed ID: 36907561 [TBL] [Abstract][Full Text] [Related]
14. Are extracellular vesicles new hope in clinical drug delivery for neurological disorders? Muhammad SA Neurochem Int; 2021 Mar; 144():104955. PubMed ID: 33412233 [TBL] [Abstract][Full Text] [Related]
15. Selection of Fluorescent, Bioluminescent, and Radioactive Tracers to Accurately Reflect Extracellular Vesicle Biodistribution Lázaro-Ibáñez E; Faruqu FN; Saleh AF; Silva AM; Tzu-Wen Wang J; Rak J; Al-Jamal KT; Dekker N ACS Nano; 2021 Feb; 15(2):3212-3227. PubMed ID: 33470092 [TBL] [Abstract][Full Text] [Related]
16. Recent Advances on Extracellular Vesicles in Central Nervous System Diseases. Jin T; Gu J; Li Z; Xu Z; Gui Y Clin Interv Aging; 2021; 16():257-274. PubMed ID: 33603351 [TBL] [Abstract][Full Text] [Related]
17. Extracellular vesicle-associated small heat shock proteins as therapeutic agents in neurodegenerative diseases and beyond. Van den Broek B; Wuyts C; Irobi J Adv Drug Deliv Rev; 2021 Dec; 179():114009. PubMed ID: 34673130 [TBL] [Abstract][Full Text] [Related]
18. Nanotechnology-Inspired Extracellular Vesicles Theranostics for Diagnosis and Therapy of Central Nervous System Diseases. Tian T; Qiao S; Tannous BA ACS Appl Mater Interfaces; 2023 Jan; 15(1):182-199. PubMed ID: 35929960 [TBL] [Abstract][Full Text] [Related]
19. EVs and Bioengineering: From Cellular Products to Engineered Nanomachines. Villata S; Canta M; Cauda V Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842627 [TBL] [Abstract][Full Text] [Related]
20. Extracellular vesicles as natural therapeutic agents and innate drug delivery systems for cancer treatment: Recent advances, current obstacles, and challenges for clinical translation. Pirisinu M; Pham TC; Zhang DX; Hong TN; Nguyen LT; Le MT Semin Cancer Biol; 2022 May; 80():340-355. PubMed ID: 32977006 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]